Introduction
Periodontal disease is perhaps the most common infectious disease in humans caused by bacteria present in the oral cavity, which attach on the teeth and cause inflammation to the surrounding (periodontal) tissues. Longitudinal epidemiological studies show that whilst 90% of the population will develop some signs of the early disease namely gingivitis, only 7-13% appear to be at high risk of developing severe destructive periodontitis (Brown and Loe, 1993) . Two main forms of destructive periodontal disease are currently recognized, chronic and aggressive periodontitis.
Aggressive periodontitis is often characterized by a rapid and severe periodontal destruction in mainly younger individuals and a tendency for cases to aggregate in families (Albandar and Rams, 2002) . In its severe forms, periodontitis may lead to loosening and drifting of the teeth and ultimately tooth loss, resulting in a significant impact on masticatory function and quality of life. Moreover, recent evidence has indicated that periodontal disease could contribute to the development of life-threating conditions namely cardiovascular disease (CVD) or stroke (Danesh et al., 1997) . The growing global burden of periodontitis creates a need to identify biomarkers for this disease, establish novel diagnostic tests, or develop new therapies directed at the attenuation of the action of these markers.
Gingival crevicular fluid (GCF) is a serum transudate or an inflammatory exudate that results from the interaction between the bacterial biofilm adherent to the tooth surfaces and the cells of the periodontal tissues (Alfano, 1974) . GCF plays a special part in maintaining the structure of junctional epithelium and in the antimicrobial defence of periodontium and acts as a medium for the transport of bacterial products into and host derived products out of the periodontal environment (Ebersole, 2003; Krasse, 1996) . The collection of GCF is a non-invasive, safe procedure, and perhaps the most applicable aid for analysis for development of diagnostic markers (Lamster et al., 1988) , since it is closely approximated to the tissues where periodontal disease begins and consequently opens to the whole body (Champagne et al., 2003) . Because GCF composition reflects the nature and amplitude of the host response to the microbial plaque challenge, determination of GCF constituent levels may help identify subjects undergoing a transition from health to disease (Bostanci et al., 2007) .
The circulating GCF proteome holds great promise as a reservoir of information that will be applicable for diagnosis of periodontal disease.
The identification of the composition of GCF as opposed to that of serum or saliva has been more challenging due to its small sample volume. Initial protein analysis of GCF has been elucidated using techniques such as crossed immunoelectrophoresis, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), twodimensional gel electrophoresis coupled with mass spectrometry (MS) and ELISA (Estreicher et al., 1996; Golub and Kleinberg, 1976; Pisano et al., 2005) . Using these approaches, more than 60 individual components of GCF have been assessed as candidate markers of disease progression (Lamster and Ahlo, 2007; Ozmeric, 2004; Uitto, 2003) . Specifically, plasma proteins, bacterial and host enzymes, various inflammatory mediators have been among the myriad components studied. Although these strategies have provided some insights, it is acknowledged that studying individually these markers is of limited value. To date, however, there is a lack of information regarding proteomic approaches and sample processing in order to analyse the expression of various proteins present in GCF. We anticipate that integrated analysis of the proteome of GCF is required to dissect fully the molecular mechanisms responsible for periodontal diseases and consequently linked systemic diseases such as CVD and diabetes mellitus (DM).
New developments in proteomic analysis technology could allow for successful analysis of the full complement of proteins in GCF. Recent reports employing labelfree quantitative liquid chromatography/tandem mass spectrometry (2D-LC-MS/MS) have demonstrated that protein profiles of oral samples such as saliva may be useful for diagnosis of DM (Rao et al., 2009 ) . More recently, a new variant of label-free quantification known as LC/MS E was introduced for quadrupole time-of-flight (QTof) mass spectrometers. For this method, alternating scans of low collision energy and elevated collision energy during LC/ MS analysis are used to obtain both protein quantification and protein identification data in a single sample (Silva et al., 2006; Silva et al., 2005) . This technology offers unique advantages including reduced sample consumption, improved detection sensitivity and enhanced data quality for proteomic studies. The aim of this study was to perform a comprehensive analysis of the GCF exudatome from healthy and periodontally diseased sites by LC/MS E . The results of the present study suggest that the current technology, which requires only a small volume of fluid, is an appropriate platform for analysis of GCF proteome and allowed us to uncover a number of proteins that were not previously known to be present in GCF.
Research Design and Methods
Subjects. From a case-control study, 10 subjects were chosen for GCF proteome analysis. The study had been reviewed and approved by the Joint UCL/UCLH Presence or absence of bleeding on probing (BOP) and plaque accumulation was recorded in a dichotomous way. If bleeding occurred within 15 sec after retrieval of the probe, the site is recorded as BOP-positive (Muhlemann and Son, 1971) . Presence of visible plaque after running the probe along the gingival margin was recorded as positive. The mean FMPS and FMPS are given as percentage (Table 1) . The healthy group consisted of 3 females and 2 males ranging in age from 27 to 38 years with a mean age of 32.4 ± 3.9 years. They exhibited PPD < 3 mm, and no radiographic evidence of alveolar bone loss. The G-AgP group consisted of 3 females and 2 males between the ages of 25 and 44 years (mean of 34.6 ± 6.9 years) with a generalized pattern of severe periodontal tissue destruction and loss of periodontal support inconsistent with age and plaque levels (Armitage, 2004 (Lamster, 1997) . Mechanical irritation avoided and the strips contaminated with blood were discarded.
The GCF sample volume was measured with a calibrated Periotron 8000 (Periotron 8000, Proflow, Inc., Amityville, NY, USA) and then the readings were converted to an actual volume (µl) by reference to the standard curve. Four samples from each subject were pooled in an Eppendorf tube prior to storing at -80°C prior to analysis.
On the day of the analysis, the GCF samples were re-eluted in 100µl PBS, then centrifuged at 13000 x g for 15 min. GCF proteins were identified and quantitated by direct analysis of the reaction mixture described above. All analyses were performed using a nanoAcquity HPLC and QTOF Premier mass spectrometer (Waters Corporation, Manchester, UK).
Peptides were trapped and desalted prior to reverse phase separation using a Symmetry C18 5µm, 5mm X 300µm pre-column. Peptides were then separated prior to mass spectral analysis using a 15cm X 75 µm C18 reverse phase analytical column.
Peptides were loaded onto the pre-column at a flow rate of 4µl / min in 0.1% formic acid for a total time of 4 mins. Peptides were eluted off the pre-column and separated on the analytical column using a gradient of 3-40% acetonitrile [0.1% formic acid] over a period of 90 min and at a flow rate of 300 nl/min. The column was washed and re-generated at 300 nl/min for 10 min using a 99% acetonitrile [0.1%] rinse. After all non-polar and non peptide material was removed the column was re-equilibrated at the initial starting conditions for 20 min. All column temp were maintained at 35 0 C.
Mass accuracy was maintained during the run using a lock spray of the peptide [glu1]-fibrinopeptide B delivered through the auxiliary pump of the nanoAcquity at a concentration of 300 fmol/l and at a flow rate of 300 nl/min.
Peptides were analysed in positive ion mode using a Q-Tof Premier mass spectrometer (Waters Corp., Manchester, UK) and was operated in v-mode with a typical resolving power of 10,000 FWHM. Prior to analyses, the TOF analyser was were colleted in a data independent and alternating, low and high collision energy mode. Each low/high acquisition was 1.5s with 0.1 sec interscan delay. Low energy data collections were performed at constant collision energy of 4 eV, high collision energy acquistions were performed using a 15-40eV ramp over a 1.5 sec time period and a complete low/high energy acquisition achieved every 3.2 sec.
Data Processing and Database Searching.
ProteinLynx GlobalServer version 2.3.5 was used to process all data acquired.
Protein identifications were obtained by searching UniProt/Swiss-Prot databases to which the sequence of yeast enolase was added manually. Protein identification from the low/high collision spectra for each sample was processed using a hierarchical approach where more than three fragment ions per peptide, seven fragment ions per protein and more than two peptides per protein had to be matched. Since single-peptide protein identifications are more likely to represent false-positive data points, all proteins with greater than two peptides identified with high confidence were considered for protein quantification. Carboamidomethylation was set as a fixed modification and oxidation was set as variable modification. The average intensity value of the top three ionizing peptides to yeast enolase was used to convert the average intensity of the top three ionizing peptides for proteins to the corresponding absolute quantity of protein loaded on column. The lowest detectable concentration was 0.1 fmol. Quantitative data in fmol was analysed in Microsoft Excel.
Enzyme-linked immunosorbent assay (ELISA)
To validate the LC/MS E findings, neutrophil defensin (HNP) was selected as marker.
HNP levels were measured in the same GCF samples by a commercially available ELISA kit, according to the manufacturer's instructions (HyCult Biotechnology, Uden, The Netherlands). The absorbance was measured at 450 nm with a wavelength correction set at 570nm, using a microplate reader (Tecan Infinite 200, Tecan Group Ltd, Switzerland). A standard curve was generated using a four parameter logistic (4-PL) curve-fit (Microsoft Office Excel). The values of the samples were assigned according to the generated standard curve. The sensitivity of the assay was 0.41 pg/ml.
Results and Discussion
Identification and Quantification of GCF Proteins.
In the present study we used label-free quantitative LC/MS E analysis approach to characterise multiple proteins simultaneously in the GCF samples collected from healthy subjects and patients with a generalized severe form of periodontal disease.
There are several reports in the literature that have investigated single potential biomarkers by employing immunoassays using this biological material (Uitto, 2003) .
To our knowledge, this is the first report to make use of the label-free LC/MS E approach for full identification and quantification of proteins in the GCF, unveiling a large number of proteins that were not previously known to be present in GCF.
The demographic and clinical data are shown in Table 1 and Table 2 . There were no significant differences between the groups in terms of gender and age (Table 1) .
Gender-mixing in a small sample size would have been a limitation if we sought to verify disease markers in such a small sample. Since the aim of the study was to evaluate if this particular method is an appropriate platform for detection of proteins in gingival crevicular fluid, a mixed gender sample in both groups is potentially more suitable in this context.
When full mouth clinical parameters of the studied subjects were compared, the GAgP group had significantly higher mean PPD, REC and FMBS (p<0.05) ( Table 1) .
G-AgP groups had also significantly higher mean PPD, REC and BS scores of sampling sites than the healthy group (P<0.05) ( Table 2 ). In contrast, no significant differences were detected between the two groups regarding the plaque levels (P>0.05).
A total of 154 proteins with at least two unique peptide hits, validated from two different runs, were identified and quantified in the two subject groups (Table 3) .
When the identified proteins are categorized based on their origin, the disease group exhibited an increase in the proportion of bacterial, yeast, and viral protein, at the expense of human-derived proteins (Figure 1 A-B) . This is rationale, as the microorganism load is expected to be higher in disease. The pie chart in Figure Greater number of proteins were identified in diseased samples (n=115) than healthy ones (n=88). Interestingly, a few markers were found exclusively in either group, whereas a greater number of them were found present in both groups, albeit at different relative levels. The putative roles of these proteins in relation to periodontal health/disease are discussed below. There was also great variability of GCF analytes between the subjects, even within the same group. The mean +/-SD value derives from five individual samples in each group. The fact that some SDs are 0.0 is due to the protein was detected only in one single sample in that group. This suggests that the protein composition of GCF is rather individual specific, and pooling of the samples from the same clinical presentation based on diagnosis may result in loss of important information. Since the sample size was small with the large SD, it was not possible to perform further statistical analysis.
Among the large number of proteins that were found in both diseased and healthy subjects, the most abundant proteins were human albumin, followed by immunoglobulins and various keratins. Previously, around 70 individual components of GCF have been assessed as potential markers for the disease (Lamster and Ahlo, 2007) . These have been mostly proteolytic enzymes and pro-inflammatory cytokines.
However, in the present study we rarely identified cytokines. This could potentially be due to their low concentrations or low molecular weight being masked by the presence of albumin or immunoglobulins (Jacobs et al., 2005) . While many studies employing proteomic technologies apply techniques to deplete serum and plasma of high-abundance proteins prior to analysis, recent studies have shown that these practices may concomitantly remove potentially important diagnostic information. For instance, human albumin is a protein vehicle within the blood stream that binds to hormones, cytokines, and lipoproteins (Dea et al., 2002) . In the present study, albumin concentration was the highest among all detected proteins which was at the level of 220.4 ± 230.9 fmol in health and 241.8 ± 240.4 fmol in periodontitis. On the contrary to cytokines, we did identify a number of enzymes associated with polymorphonuclear neutrophils (PMNs), such as matrix metalloproteinase-8 (MMP-8), cathepsin G and myeloperoxidase, all of which were previously identified and proposed as candidate diagnostic markers for periodontal disease (Sorsa et al., 1999; Tervahartiala et al., 1996; Yamalik et al., 2000) . Interestingly, MMP-8 and cathepsin G were not detected in GCF samples from healthy sites, but were present in periodontitis. MMPs are a family of zinc-dependent endopeptidases that are expressed in many inflammatory conditions including periodontitis and contribute to connective tissue breakdown. The fact that some other MMPs were not detected by this method, despite that they have been detected by conventional protein detection assays suggests that the current method has its limitations. In the case of relatively low abundant proteins, such as MMPs and potentially cytokines, a drop of peptide signal is still a limiting factor for detection. Selective enrichment or depletion of the highly abundant GCF proteins prior to mass spectrometric analysis may help overcome this problem (Freije et al., 2008) . Although the current approach was quite successful, clearly there is more room for improvement identifications of whole GCF proteins.
Myeloperoxidase was detected only in one out of five healthy samples, but in all periodontitis samples, which was on average 2-fold greater. Other proteins in the diseased group were most notably heat shock protein 70 kDa (HSP70). HSP70 has been shown to be an activator of the innate immune system (Kiang and Tsokos, 1998) and its release can be induced by periodontal pathogens (Saba et al., 2007) .
Among the proteins not previously identified in GCF, the present data indicates that L-plastin (Plastin-2), also known as lymphocyte cytosolic protein 1, is of special interest. This protein was not detected in any of the five healthy samples, whereas it was present in 4 out of 5 diseased samples, with a mean concentration of 15.6 ± 12.1 fmol. L-plastin belongs to the actin-binding protein family, which is found in cells of the hematopoetic origin such as leukocytes. A role for L-plastin in the regulation of leukocyte adhesion and PMN signal transduction has been suggested (Jones et al., 1998) . However, there is no known literature suggesting a role for L-plastin in periodontal disease. Higher concentrations of this protein in GCF may facilitate recruitment of PMNs at sites of inflammation. This may be relevant in view of the potential constitutive PMN hyper-reactivity in periodontitis patients (Matthews et al., 2007) .
In contrast, cystatin B and neutrophil defensins were not detected in any of the periodontitis group samples. The average concentrations in health were 11.7 ± 10.4
fmol for cystatin B, and 14.8 ± 3.4 fmol for neutrophil defensin. A commercially available ELISA for human neutrophil defensin was also employed to validate the findings from the proteomic analysis. Accordingly, human neutrophil defensin levels were under detection limit in the periodontal disease samples, whereas the mean concentration of the healthy samples was 125.13 ± 129.04 ng/ml. These findings are consistent with the LC/MS E data, as well as previously published data (Lundy et al., 2005) . The fact that neutrophil defensin, which has an antimicrobial properties was absent in the diseased samples supports the idea that the progression of periodontal disease could be linked to a decrease in the defensin barrier (Lundy et al., 2005) . To this extent, defensins are suggested to have an important protective role for the host immune response to infection by periodontal pathogens (Brogden et al., 2003) .
Cystatin B, a neutral cysteine proteinase inhibitor, belonging to the cystatin family that minimizes proteolysis-associated tissue damage in inflammation (Chen et al., 1998; Dickinson, 2002) . Proteins belong to the cystatin family such cystatin A, but not cystatin B, C or S, have previously been detected in GCF by immunoblotting or ELISA (Blankenvoorde et al., 1997) . Cystatin B in particular could have been derived from serum, or from local cellular secretions such as monocytes, epithelial cells and PMNs (Jarvinen et al., 1987) .
Members of the calcium binding protein family including Calgranulin B, S100-P and
Annexins were also differentially present in GCF. The S100 family proteins are thought to modulate biological activity via calcium binding and they expressed by macrophages and by epithelial cells in acutely inflamed tissues (Marenholz et al., 2004) . Annexins are a group of Ca 2+ -binding proteins that are associated with inflammatory and defense responses (Perretti and D'Acquisto, 2009 ). In the present study, annexin-1 appears to be more associated with a healthy status, since it was more frequently detected in health (four out of five samples in health vs two out of five in disease) and at 5-fold higher levels compared to disease. Likewise, Annexin-2 was not detected in any of the disease samples, but was found in two out of five healthy samples, at a mean concentration of 3.5 ± 1.7 fmol. Annexin-1 has long been suggested to be a critical endogenous negative regulator of pro-inflammatory mediators including IL-1, IL-6 and cyclooxygenase-2 (Parente and Solito, 2004) . In several disease models, such as experimental animal models of endotoxemia or arthritis, absence of Annexin-1 has been associated with increased levels of cytokines and exacerbation of acute inflammation (Damazo et al., 2005; Yang et al., 1999) .
Therefore, it is tempting to postulate that the higher levels of annexins in GCF may be associated with a healthy periodontal status, or that reduced levels or absence may have a potential to explain many aspects of inflammatory status in periodontal disease.
These proteins, which were mainly found in health, may have an important protective role and their function in periodontal disease needs to be addressed in a larger cohort of patient samples.
Other proteins of the immune system, such as α 1 -antitrypsin, α 1 -1-antichymotrypsin, α-1-acid glycoprotein, immunoglobulins (Ig) were also identified. α 1 -antitrypsin was detected in two out of five healthy samples (30.0 ± 15.2 fmol), but was found in only one disease sample (2.4 ± 0.0 fmol). Presence of α-1-antitrypsin in GCF has been previously reported (Cox et al., 2006) . Deficiencies in α-1-antitrypsin are known to predispose individuals to destructive inflammatory disease, including periodontitis (Peterson and Marsh, 1979; Yang et al., 2000) . The balance between proteases and protease inhibitors is critical for maintenance of healthy tissue, and imbalances may lead to tissue destruction. The α-1-acid glycoprotein is one of the acute phase proteins, which is increased in response bacterial infection. In addition, its serum concentrations remain stable under physiological conditions (Fournier et al., 2000; Hochepied et al., 2003) .A comparison of the healthy samples versus the diseased ones showed that α-1-acid glycoprotein 1 levels were up-regulated by 2-fold in periodontitis. Higher levels of this molecule have been previously reported in the sera of subjects with periodontitis (Glurich et al., 2002) .
Confirming previous reports (Eley and Cox, 2003; Mooney and Kinane, 1997; Reinhardt et al., 1989; Wilton et al., 1993) , GCF was enriched with immunoglobulins including four IgG subclass proteins and IgA. IgG concentrations were lower in GCF from patients with periodontitis than healthy ones. IgG1 protein was detected in both health and disease and was at highest concentration in healthy samples (86.2 ± 61.5 fmol). IgG3 was not present in any of the disease samples, whereas its mean concentration in health was 11.6 ± 0.0 fmol. IgA was present only in health (in 2 samples out of 5) with a mean concentration of 4.7 ± 2.5 fmol. Immunoglobulins arrive at the periodontal lesion site from both systemic and local tissue sources. The relative abundance of immunoglobulins in GCF may play a crucial role in the local defence mechanisms.
Notably, twenty-five different keratins were identified and quantified in GCF.
However, this is not surprising since a great complexity of cytokeratins have been shown to be expressed in the gingiva or periodontal pockets (Mackenzie and Gao, 1993; Mackenzie et al., 1991; Ouhayoun et al., 1985) . Although it should not be excluded that keratins are usual contaminants from the air, skin or hair, in the present study this was controlled for by simultaneous digestion of all samples. The present results indicated different and distinctive patterns of keratin protein expression in healthy and diseased GCF. For instance, cytokeratins 12 and 23 were only present in GCF from healthy sites, whereas cytokeratin 1 was consistently found in all samples.
Other cytokeratins were detected at variable levels, but clearly their concentrations were lower in periodontal disease compared to health. This may be expected since the normal turnover rate of healthy sulcular epithelium is known to be one of the most rapid of all the epithelial tissues (Rowat and Squier, 1986) . Therefore, it would be expected that healthy GCF contains large number of cytokeratins resulting from this vigorous turnover. In periodontal disease, where the periodontal pocket epithelium is ulcerated, the presence of cytokeratins in GCF may be attributed to passive release due to epithelial cell detachment or lysis (Ouhayoun et al., 1990 ).
There were also proteins from bacteria, viruses and yeast present in the GCF, since protein identification searches were not only limited to human protein sequence database. Evidently, greater proportions of these organisms are present in the GCF samples from periodontal disease than healthy ones. The higher presence of viral proteins, such as herpes virus protein 2, in the diseased samples corroborates previous reports that support the involvement of viral infection in the pathogenesis of periodontal disease (Slots, 2007) . Interestingly, no proteins from putative periodontal pathogens were detected in any of the diseased samples, with one exception, the methylmalonyl-CoA mutase of Porphyromonas gingivalis, which is one of the major pathogens implicated in periodontitis (Curtis et al., 2001) . Although previous studies have shown that P. gingivalis proteolytic enzymes can be detectable in GCF (Aas et al., 2007) , the present approach may not be optimal for the detection of periodontal pathogens. Notably, E. coli proteins were detected in GCF of both healthy and periodontally diseased subjects. Since the oral cavity is not a natural habitat for E.
coli, the presence of its proteins in GCF detected in the present study may reflect their transfer from non-oral sites via the serum route.
Conclusions
The findings of the present study demonstrate that label-free quantitative LC/MS E based mass spectrometry technology is an appropriate platform for the analysis of 
